← Open Payments lookup

REBECCA REARICK: Open Payments

NPI 1437934643 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,306 in 81 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,019 · 2025 $1,306

Food & beverage: $1,306
CompanyPaymentsAmount
ABBVIE INC.17$261
Amgen Inc.14$214
Novo Nordisk Inc12$175
Lilly USA, LLC14$164
AstraZeneca Pharmaceuticals LP6$142
Astellas Pharma US Inc5$100
Neurocrine BioSciences, Inc.3$76
PFIZER INC.4$62
Exact Sciences Corporation3$59
Boehringer Ingelheim Pharmaceuticals, Inc.1$24

Products named: Ozempic, MOUNJARO, VRAYLAR, EVENITY, Veozah, QULIPTA, BREZTRI, INGREZZA.

Industry payments across IN — which companies pay providers there.